FDA Stresses Dangers Of Transplant Drugs

Law360, New York (May 19, 2008, 12:00 AM EDT) -- Federal regulators warned again Friday that organ-transplant drugs made by Roche Holding AG and Novartis AG cause miscarriages and birth defects when taken by pregnant women.

The U.S. Food and Drug Administration initially released warnings and revised the labels for Roche's CellCept and Novartis' Myfortin drugs in November amid reports of miscarriages and ear and mouth deformities in infants after their mothers took the drugs to prevent organ rejection.

The drugs are used to suppress the body's immune system to avoid organ rejection in transplant patients....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.